Literature DB >> 31832260

High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure.

Megan K Skelly1,2,3, Tammie Lee Demler1,2,3, Claudia Lee1,2,3.   

Abstract

Clozapine, a second-generation antipsychotic (SGA), is known for its superior efficacy in the treatment of refractory schizophrenia. Clozapine's hallmark side effects are well-known, including, but not limited to, drug-induced seizures associated with daily goal doses greater than 600mg and rapid dose escalation, which can also contribute to significant risk of orthostatic hypotension, bradycardia, and syncope. However, less well-known is the potential withdrawal that can occur from its rapid discontinuation. Here, we describe a case of seizure-like activity that occurred 72 hours after an abrupt high-dose clozapine discontinuation in a patient with schizoaffective disorder, bipolar type. Seizures, although known to be a high-serum-concentration-dependent side effect of clozapine, could not be excluded as a possible withdrawal syndrome in this patient.
Copyright © 2019. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Clozapine; psychopharmacology; seizure; withdrawal

Year:  2019        PMID: 31832260      PMCID: PMC6850498     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  21 in total

1.  Clozapine withdrawal symptoms in a Parkinson's disease patient.

Authors:  Theresa A Zesiewicz; Sujatha Borra; Robert A Hauser
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Benzodiazepine withdrawal seizures and management.

Authors:  Xiaohong Hu
Journal:  J Okla State Med Assoc       Date:  2011-02

3.  Organic catatonia following frontal lobe injury: response to clozapine.

Authors:  O Rommel; M Tegenthoff; W Widdig; P Bräunig; J P Malin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

4.  Neuroleptic-induced supersensitivity psychosis.

Authors:  G Chouinard; B D Jones; L Annable
Journal:  Am J Psychiatry       Date:  1978-11       Impact factor: 18.112

5.  Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

Authors:  P Hartvig; S A Eckernäs; L Lindström; B Ekblom; U Bondesson; H Lundqvist; C Halldin; K Någren; B Långström
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 6.  [Clozapine withdrawal. A review].

Authors:  T Szafrański; K Gmurkowski
Journal:  Psychiatr Pol       Date:  1999 Jan-Feb       Impact factor: 1.657

7.  Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.

Authors:  T M Shiovitz; T L Welke; P D Tigel; R Anand; R D Hartman; J J Sramek; N M Kurtz; N R Cutler
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

8.  Clozapine plasma levels and convulsions.

Authors:  G M Simpson; T A Cooper
Journal:  Am J Psychiatry       Date:  1978-01       Impact factor: 18.112

9.  Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.

Authors:  Tammie Lee Demler; Nicole E Morabito; Charlene E Meyer; Lewis Opler
Journal:  Int Clin Psychopharmacol       Date:  2016-03       Impact factor: 1.659

10.  Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature Review.

Authors:  John Bilbily; Betsy McCollum; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2017-03-15
View more
  1 in total

1.  Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice.

Authors:  Geng-Ruei Chang; Hsien-Yueh Liu; Wei-Cheng Yang; Chao-Min Wang; Ching-Fen Wu; Jen-Wei Lin; Wei-Li Lin; Yu-Chen Wang; Tzu-Chun Lin; Huei-Jyuan Liao; Po-Hsun Hou; Chee-Hong Chan; Chuen-Fu Lin
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.